Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014

Am J Hematol. 2014 May;89(5):457-8. doi: 10.1002/ajh.23687. Epub 2014 Mar 7.
No abstract available

MeSH terms

  • Enzyme Replacement Therapy / methods*
  • Gaucher Disease / diagnosis
  • Gaucher Disease / drug therapy*
  • Gaucher Disease / enzymology
  • Glucosylceramidase / therapeutic use
  • Humans
  • Insurance, Health
  • United States

Substances

  • Glucosylceramidase
  • Velaglucerase alfa, human
  • taliglucerase alfa
  • imiglucerase